MARUWA: AI sales expected to accelerate from 2H, Buy maintained
AI summary card
MARUWA: AI sales expected to accelerate from 2H, Buy maintained
Goldman Sachs maintains a Buy rating on MARUWA, believing that the launch of a new plant, ramp-up of CPO products, and a higher share of high value-added products will drive AI-related sales into an acceleration phase.
- FY3/27 guidance is considered fairly conservative, but the earnings briefing conveyed a positive outlook for the AI business.
- The company expects sales of next-generation 1.6T-related products to grow steadily in line with customer forecasts, with CPO products beginning to ramp in 2H FY3/27 and reaching full scale-up at the start of the next fiscal year.
- Seto Plant No. 1 is currently running at about 70% capacity utilization; Plant No. 2 has completed construction and is entering equipment start-up, and Plant No. 3 is scheduled to start operations in FY3/28.
- The market reacted strongly to the AI business outlook; the report notes that by the morning close after the earnings briefing, the share price was up 11.6% from the previous close, while TOPIX rose 1.0% over the same period.
Report interpretation
Overview
This report is Goldman Sachs' company research/earnings review of MARUWA (5344.T) following the earnings briefing. The core conclusion is that FY3/27 guidance is conservative, while AI-related business is expected to enter an acceleration phase from 2H on the combined effect of new plant start-up, a higher share of high value-added products, expanding CPO contribution, and end-market expansion, so the firm maintains its Buy rating.
Core views
The most important takeaway is that MARUWA's AI business growth is driven not only by market expansion but also by company-specific factors, including a higher share of high value-added products and capacity expansion. Demand for next-generation 1.6T products is expected to grow steadily, CPO products will begin ramping in 2H FY3/27, and may reach full scale-up at the start of the next fiscal year. The company's position as a major supplier of CPO products remains unchanged.
Analysis framework
The analysis is based on management comments from the earnings briefing, product-by-product and capacity expansion cadence, customer forecasts, the target-price valuation framework, and Goldman Sachs' forecast table. The valuation uses FY27E EBITDA and derives a 12.1x multiple from the historical correlation between EBITDA margin and the EV/EBITDA multiple.
Methodology notes
Target price valuation
The 12-month target price of ¥70,000 is based on FY27E EBITDA, applying a 12.1x EV/EBITDA multiple; this multiple is derived from the historical correlation between EBITDA margin and the EV/EBITDA multiple.
Goldman Sachs factor profile
The Goldman Sachs factor profile compares a stock's relative Growth, Financial Returns, Multiple, and Integrated attributes versus the market and peers; Growth is based on forward sales, EBITDA, and EPS growth, Financial Returns on ROE, ROCE, and CROCI, and Multiple on valuation indicators such as P/E, P/B, P/D, and EV/EBITDA.
M&A probability score
Goldman Sachs uses an M&A rank from 1 to 3 to assess the probability of being acquired, where 1 indicates high probability, 2 indicates medium probability, and 3 indicates low probability; the chart in this report shows MARUWA's M&A rank as 3.
Goldman Sachs financial database
Quantum is Goldman Sachs' proprietary database used to access detailed historical financial statements, forecasts, and ratios, and can be used for deep single-company analysis as well as cross-industry and cross-market comparisons.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- MARUWA (5344.T)Core coverage target
- Strengths
- AI-related sales are expected to accelerate; its position as a major CPO supplier remains unchanged; capacity expansion is progressing; the share of high value-added products is rising; negative net debt/EBITDA indicates a net cash position.
- Weaknesses
- Near-term valuation is not low, with FY3/27E P/E at 30.5x; upside to the target price versus the current share price is about 3.8%, leaving limited margin of safety.
- Comparison
- The report discloses that its rating ranks it alongside other covered Japanese electronic components/semiconductor companies such as Alps Alpine, Dai Nippon Printing, Hirose Electric, Murata Mfg., Renesas Electronics, Rohm, and TDK.
- Risks
- Demand-related investment in end markets falls short of expectations, supply-chain disruptions or inventory adjustments reduce end-product demand, or substitute technologies emerge.
Key data
- RatingBuyThe report reiterates its Buy rating on MARUWA.
- 12-month target price¥70,000Implied FY27 P/E of about 23x; about 3.8% upside from the current price of ¥67,410.
- Current price¥67,410Valuation snapshot price shown in the chart.
- Post-briefing stock reaction+11.6%As of the morning close, up versus the previous close; TOPIX rose 1.0% over the same period.
- Seto Plant No. 1 capacity utilizationabout 70%The company is placing additional equipment orders in line with demand.
- Seto Plant No. 3 production startFY3/28Planned for AI applications, with new market production also under consideration.
- FY3/27E revenue¥94.2bnGoldman Sachs forecast table; FY3/26 was ¥74.5bn.
- FY3/29E revenue¥132.4bnForecast indicates revenue growth from FY3/26 through FY3/29E.
- FY3/27E operating profit¥38.0bnGoldman Sachs forecast table; FY3/29E was ¥66.0bn.
- FY3/27E EPS¥2,213.2Goldman Sachs forecast table; FY3/29E was ¥3,794.1.
- FY3/27E P/E30.5xForecast P/E declines to 17.8x by FY3/29E.
- Market cap¥831.7bn / $5.3bnMarket data from the chart.
Impact & implications
If the report's view holds, MARUWA's investment case will shift from a simple cyclical recovery in electronic component demand to structural growth driven by AI servers, 1.6T, and CPO-related high value-added products. Capacity expansion improves the company's ability to capture demand, but near-term share price performance has already reflected the AI outlook strongly, leaving limited upside to the target price.
Risks
- Investment in applications supporting end demand falls short of expectations, including AI/general-purpose servers, xEV, and SPE.
- Supply-chain disruptions and inventory adjustments reduce demand for end products.
- The emergence of substitute technologies weakens the competitiveness of MARUWA's existing products or CPO-related products.
- If AI-related orders, CPO ramp-up, or new plant start-up proceeds more slowly than expected, growth realization may be affected.
- The share price has already risen sharply on the AI outlook, leaving limited upside to the target price.
What to watch
- Pace of CPO product ramp-up in 2H FY3/27 and validation of customer orders.
- Whether sales of next-generation 1.6T products grow steadily in line with customer forecasts.
- Additional equipment orders and capacity utilization changes at Seto Plant No. 1.
- Mass-production progress after equipment start-up at Seto Plant No. 2.
- FY3/28 start-up plan for Seto Plant No. 3 and whether new markets beyond AI are developed.
- Investment intensity in AI/general-purpose servers, xEV, and SPE end markets.
- Whether Goldman Sachs' target price, earnings forecasts, and implied P/E and EV/EBITDA valuations continue to be revised upward.